2019.01.25 ( Fri )

Court Approves Cryotec’s Assertion Of 100% Survival As Legitimate

Tokyo District Court rejected Kitazato Corporation’s claim that REPROLIFE’s assertion of “100% post-thaw survival” is false and should be removed from all advertisements on media and sales tools.


The court says that Kitazato’s claim is insufficient to prove that the Cryotec Method is incapable of achieving a 100% survival rate as REPROLIFE asserts and therefore there is no possibility that this will cause misunderstanding by researchers or medical practitioners.


Now it is legitimate that the Cryotec Method is capable of achieving 100% survival by an embryologist who is trained and follows the protocol in every detail.